Answers are grounded in this paper and cite their sources.
The rapid emergence of antimicrobial resistant Gram-negative bacteria compromises current antibiotic efficacy, including the last-resort antibiotic polymyxins, emphasizing the urgent need for novel therapeutic strategies. Nanoscale-based antimicrobials exhibit potential as an alternative treatment strategy. In this study, four furoxan-based nitric oxide (NO)-releasing nanoparticles (NPs) were prepared and their antimicrobial efficacy was tested against different Gram-negative bacteria, including: Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli via minimum inhibitory testing, where NPs exhibited selective activity against lipopolysaccharide (LPS)-deficient A. baumannii strains and LPS-truncated strains tested. Advanced microscopic techniques and mechanistic investigations using model membranes mimicking the LPS-deficient A. baumannii membrane and LPS-containing membrane, via neutron reflectometry and small-angle neutron scattering, indicated that the NPs specifically destabilize the LPS-deficient A. baumannii membrane, leading to the release of cellular content. This work provides mechanistic insight into the selective activity of the NPs against LPS-deficient A. baumannii and their lack of efficacy in strains with LPS, highlighting membrane-level determinants that may inform future antimicrobials development.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: